EGLN3 anticorps (AA 1-120)
-
- Antigène Voir toutes EGLN3 Anticorps
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
-
Épitope
- AA 1-120
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EGLN3 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant Human Egl nine homolog 3 protein (1-120AA)
- Isotype
- IgG
- Top Product
- Discover our top product EGLN3 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
- Autre désignation
- EGLN3 (EGLN3 Produits)
- Synonymes
- anticorps zgc:77019, anticorps wu:fj78a08, anticorps EGLN3, anticorps phd3, anticorps PHD-3, anticorps PHD3, anticorps SM-20, anticorps 2610021G09Rik, anticorps AI505553, anticorps AI648162, anticorps Hif-p4h-3, anticorps Phd3, anticorps HIFP4H3, anticorps HIFPH3, anticorps egl-9 family hypoxia-inducible factor 3, anticorps egl-9 family hypoxia inducible factor 3, anticorps egl-9 family hypoxia-inducible factor 3 L homeolog, anticorps egln3, anticorps EGLN3, anticorps egln3.L, anticorps Egln3
- Sujet
-
Background: Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF2A. Hydroxylation on the NODD site by EGLN3 appears to require prior hydroxylation on the CODD site. Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. EGLN3 is the most important isozyme in limiting physiological activation of HIFs (particularly HIF2A) in hypoxia. Also hydroxylates PKM in hypoxia, limiting glycolysis. Under normoxia, hydroxylates and regulates the stability of ADRB2. Regulator of cardiomyocyte and neuronal apoptosis. In cardiomyocytes, inhibits the anti-apoptotic effect of BCL2 by disrupting the BAX-BCL2 complex. In neurons, has a NGF-induced proapoptotic effect, probably through regulating CASP3 activity. Also essential for hypoxic regulation of neutrophilic inflammation. Plays a crucial role in DNA damage response (DDR) by hydroxylating TELO2, promoting its interaction with ATR which is required for activation of the ATR/CHK1/p53 pathway. Target proteins are preferencially recognized via a LXXLAP motif.
Aliases: Egl 9 family hypoxia inducible factor 3 antibody, Egl nine homolog 3 (C. elegans) antibody, Egl nine homolog 3 antibody, Egl nine like protein 3 isoform antibody, EGL9 homolog of C. elegans 3 antibody, EGLN3 antibody, EGLN3_HUMAN antibody, Factor responsive smooth muscle protein antibody, HIF Prolyl Hydroxylase 3 antibody, HIF-PH3 antibody, HIF-prolyl hydroxylase 3 antibody, HIFP4H3 antibody, HIFPH3 antibody, HPH-1 antibody, HPH-3 antibody, Hypoxia-inducible factor prolyl hydroxylase 3 antibody, P4H3 antibody, PHD3 antibody, Prolyl Hydroxylase Domain Containing Protein 3 antibody, Prolyl hydroxylase domain-containing protein 3 antibody, SM20 antibody
- UniProt
- Q9H6Z9
- Pathways
- Positive Regulation of Endopeptidase Activity
-